Management strategies for right-to-left intraatrial shunt with thrombus in transit: a systematic review of 297 patients and associated mortality outcomes
Therapeutic Advances in Cardiovascular Disease · 2026-10 · 20
DOI: 10.1177/17539447261445315 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 27.10.2026. Verfasst von Mustafa Alkhawam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Embolism, Paradoxical, Heart Septal Defects, Atrial, Thrombosis. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Thrombus in transit (TIT) through a patent foramen ovale (PFO) or atrial septal defect (ASD) is a rare but potentially life-threatening condition associated with paradoxical embolism. Despite advances in imaging and interventional techniques, optimal management strategies remain poorly defined.
Objectives
To systematically characterize the clinical presentation, diagnostic approaches, management strategies, and outcomes of adult patients with TIT across right-to-left intra-atrial shunts.
Design
Systematic review of published cases. Data sources and methods: Following PRISMA guidelines, PubMed, Embase, and Scopus were searched from inception through March 2025 for case reports, case series, and letters describing adult patients with TIT visualized by transthoracic or transesophageal echocardiography. After screening 1736 records, 278 studies reporting 297 patients were included. Two independent reviewers extracted demographic, clinical, imaging, treatment, and outcome data. Descriptive statistics were summarized, and treatment groups were compared using chi-square and Mann–Whitney U tests. Kaplan–Meier survival curves with log-rank testing assessed 120-day survival, and multivariable Cox regression was used to evaluate potential predictors of mortality.
Results
A total of 297 patients from 278 studies were included. The mean age was 58.5 ± 15.8 years, and 50.2% were male. Respiratory symptoms predominated (77.7%), followed by cardiac (29.7%) and neurological (23.0%) manifestations. Provoked events accounted for 70.3% of cases, most commonly in the postoperative setting. Thrombi were detected by transthoracic echocardiography in 92.1% of cases and by transesophageal echocardiography in 100%. Management strategies included surgical embolectomy (57.8%), anticoagulation (36.5%), thrombolysis (13.5%), and percutaneous aspiration (2.7%); 61.1% underwent PFO/ASD closure. Overall mortality was 8.3%. Surgical management was associated with the lowest mortality (3.0%) and the highest short-term clinical improvement (90.5%; p < 0.001). Thrombolysis and percutaneous aspiration were associated with higher mortality (16.6% and 25.0%, respectively). Kaplan–Meier analysis demonstrated superior 120-day survival with surgical management compared with other treatment strategies (log-rank p < 0.001). In multivariable Cox models, no independent predictors of mortality were identified.
Conclusion
In this largest synthesis of TIT cases to date, surgical management and PFO/ASD closure were associated with favorable short-term outcomes. Surgical intervention demonstrated the lowest observed mortality, while anticoagulation provided acceptable outcomes in selected patients. Thrombolysis and percutaneous aspiration were associated with higher mortality. These findings support the role of definitive management and shunt closure in selected patients, although prospective studies are needed to establish standardized treatment strategies.
Trial registration
This study was registered in the International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY) (Registration number: INPLASY202630021).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
- Tinsley Harrison Internal Medicine Residency Program, University of Alabama at Birmingham, AL, USA.
- Department of Neurology, Division of Cerebrovascular Disease/Comprehensive Stroke Center, University of Alabama at Birmingham, Birmingham, AL, USA.
- Cardiac Network and Interventional Cardiology, Division of Cardiovascular Disease, University of Alabama at Birmingham (UAB), 619 19th Street South, Birmingham, AL 35249, USA.
ORCID-Profile: Mustafa Alkhawam, Jack Simmons
Zitieren
APA
Alkhawam, M., Simmons, J., Ray, T., Wong, R. W., Cooke, B. J., Sghayyer, M., Ahmad, Y., Nguyen, S., Pridemore, A., Ebrahimi, A. J., Bakradze, E., & Ahmed, M. I. (2026). Management strategies for right-to-left intraatrial shunt with thrombus in transit: a systematic review of 297 patients and associated mortality outcomes. Therapeutic Advances in Cardiovascular Disease, 20. https://doi.org/10.1177/17539447261445315
Vancouver
Alkhawam M, Simmons J, Ray T, Wong RW, Cooke BJ, Sghayyer M, et al. Management strategies for right-to-left intraatrial shunt with thrombus in transit: a systematic review of 297 patients and associated mortality outcomes. Therapeutic Advances in Cardiovascular Disease. 2026;20. doi:10.1177/17539447261445315
BibTeX
@article{Alkhawam2026,
author = {Alkhawam, Mustafa and Simmons, Jack and Ray, Trent and Wong, Ryan W and Cooke, Brett J and Sghayyer, Moses and Ahmad, Yaser and Nguyen, Scott and Pridemore, Aubrey and Ebrahimi, Ali J and Bakradze, Ekaterina and Ahmed, Mustafa I},
title = {Management strategies for right-to-left intraatrial shunt with thrombus in transit: a systematic review of 297 patients and associated mortality outcomes},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2026},
volume = {20},
doi = {10.1177/17539447261445315}
}
EUVIMED